ACETYLATOR PHENOTYPING: A COMPARISON OF THE ISONIAZID AND DAPSONE TESTSHANSON A; MELANDER A; WAHLIN BOLL E et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 3; PP. 233-234; BIBL. 9 REF.Article

CHARACTERIZATION OF HUMAN LYMPHOCYTE N-ACETYLTRANSFERASE AND ITS RELATIONSHIP TO THE ISONIAZID ACETYLATOR POLYMORPHISMMCQUEEN CA; WEBER WW.1980; BIOCHEM. GENET.; ISSN 0006-2928; USA; DA. 1980; VOL. 18; NO 9-8; PP. 889-904; BIBL. 1 P.Article

ACETYLATION PHENOTYPE IN RHEUMATOID ARTHRITIS.OKA M; SEPPAELAE O.1978; SCAND. J. RHEUMATOL.; SWED.; DA. 1978; VOL. 7; NO 1; PP. 29-30; BIBL. 12 REF.Article

A SEMI-AUTOMATED BRATTON & MARSHALL MICROMETHOD FOR DETERMINING ACETYLATOR PHENOTYPE OF RABBITS USING THE ABBOTT BICHROMATIC ANALYZER-100WHITEHOUSE LW; PAUL CJ.1979; J. CLIN. CHEM. CLIN. BIOCHEM.; DEU; DA. 1979; VOL. 17; NO 8; PP. 533-536; ABS. GER; BIBL. 9 REF.Article

NORMAL DISTRIBUTION OF ACETYLATION PHENOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUS.VANSANT J; WOOSLEY RL; JOHN JT et al.1978; ARTHRIT. AND RHEUMATISM; U.S.A.; DA. 1978; VOL. 21; NO 2; PP. 192-195; BIBL. 17 REF.Article

HYDRALAZINE-INDUCED PERIPHERAL NEUROPATHY SEEN IN A JAPANESE SLOW ACETYLATOR PATIENTTSUJIMOTO G; HORAI Y; ISHIZAKI T et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 6; PP. 622-625; BIBL. 22 REF.Article

TEST D'ACETYLATION DE L'INH. RESULTATS PRELIMINAIRES CHEZ 21 MAGHREBINSBELKAHIA C; NACEF B; BRAZIER JL et al.1980; TUNISIE MED.; ISSN 0041-4131; TUN; DA. 1980; VOL. 58; NO 5; PP. 662-664; ABS. ARA/ENG; BIBL. 14 REF.Article

ISONIAZID LEVELS IN BLACK PATIENTS DOSED WITH A MATRIX PREPARATION (TEBESIUM).GLATTHAAR E; GARTIG D; STANDER MF et al.1977; PRAXIS KLIN. PNEUMOL.; DTSCH.; DA. 1977; VOL. 31; NO 10; PP. 885-889; ABS. ALLEM.; BIBL. 18 REF.Article

THE ACETYLATOR POLYMORPHISM IN FOUR POPULATIONS OF AFGHANISTAN.GOEDDE HW; FLATZ G; RAHIMI AG et al.1977; HUM. HERED.; SWITZ.; DA. 1977; VOL. 27; NO 5; PP. 383-388; BIBL. 18 REF.Article

PHENOTYPE D'ACETYLATION DE L'ISONIAZIDE AU MAROC: ETUDE PRELIMINAIRE SUR 100 CASBOUAYAD Z; CHEVALIER B; MAURIN R et al.1982; REV. MAROC. MED. SANTE; ISSN 0251-0758; MAR; DA. 1982; VOL. 4; NO 1; PP. 13-18; ABS. ENG/ARA; BIBL. 19 REF.Article

A SIMPLE PHARMACOKINETIC METHOD FOR SEPARATING THE THREE ACETYLATION PHENOTYPES: A PRELIMINARY REPORTLEE EJD; LEE LKH.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 3; PP. 375-378; BIBL. 19 REF.Article

ROLE OF N-ACETYLTRANSFERASE PHENOTYPE IN HUMAN SUSCEPTIBILITY TO BLADDER CARCINOGENIC ARYLAMINESWOLF H; LOWER GM JR; BRYAN GT et al.1980; SCAND. J. UROL. NEPHROL.; ISSN 0036-5599; SWE; DA. 1980; VOL. 14; NO 2; PP. 161-165; BIBL. 16 REF.Article

PHENOTYPING OF ISONIAZID INACTIVATORS IN GREEKSGIANNOPOULOS Z; DOZI VASSILIADES J; GRANITSAS A et al.1979; FOLIA BIOCHIM. BIOL. GRAECA; GRC; DA. 1979; VOL. 16; NO 3-4; PP. 91-94; BIBL. 10 REF.Article

LOCALISATION DES N-ACETYLTRANSFERASES DANS LES CELLULES SINUSOIDALES HEPATIQUES. INFLUENCE DU ZYMOSAN SUR L'ACETYLATION DE LA SULFAMETHAZINE ET DE L'ISONIAZIDE CHEZ LE RAT ET DANS LE FOIE ISOLE PERFUSENOTTER D; ROLAND E.1978; C.R. SOC. BIOL.; FRA; DA. 1978; VOL. 172; NO 3; PP. 531-533; ABS. ENG; BIBL. 7 REF.Article

ACETYLATOR PHENOTYPE IN DIABETIC NEUROPATHY.MCLAREN EH; BURDEN AC; MOORHEAD PJ et al.1977; BRIT. MED. J.; G.B.; DA. 1977; VOL. 2; NO 6082; PP. 291-293; BIBL. 11 REF.Article

COLORIMETRIC OR HPLC METHOD FOR ACETYLATOR PHENOTYPING WITH SULFADIMIDINE.OLSEN H.1982; ACTA PHARMACOL. TOXICOL.; ISSN 0001-6683; DNK; DA. 1982; VOL. 50; NO 1; PP. 75-77; BIBL. 11 REF.Article

POTENTIAL INFLUENCE OF BODY WEIGHT ON THE CLEARANCE OF POLYMORPHICALLY ACETYLATED DRUGSCHAPRON DJ; KRAMER PA; MERCIK SA et al.1982; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1982; VOL. 22; NO 5/6; PP. 271-275; BIBL. 25 REF.Article

EVALUATION OF THE SULPHADIMIDINE ACETYLATOR PHENOTYPING TEST IN PATIENTS WITH REDUCED RENAL FUNCTIONHALL S.1981; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1981; VOL. 209; NO 6; PP. 505-507; BIBL. 9 REF.Article

KINETIC DISCRIMINATION OF THREE SULFAMETHAZINE ACETYLATION PHENOTYPESCHAPRON DJ; KRAMER PA; MERCIK SA et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 1; PP. 104-113; BIBL. 28 REF.Article

THERAPEUTIC DRUG MONITORING: ANTIHYPERTENSIVE AGENTSBATEMAN DN; SANDERS GL; RAWLINS MD et al.1980; THER. DRUG MONIT.; USA; DA. 1980; VOL. 2; NO 2; PP. 127-132; BIBL. 48 REF.Article

ACETYLATION DES SULFAMIDES: INTERET DE SA MESURE EN CAS DE CHIMIOTHERAPIE PAR L'ASSOCIATION ISONIAZIDE-RIFAMPICINE OU: COMMENT PREVOIR LA TOXICITE DES ANTITUBERCULEUXBESSOT JC; BURGHARD G; SCHMIDT M et al.1980; J. MED. STRASBOURG; FRA; DA. 1980; VOL. 11; NO 4; PP. 197-199; ABS. ENG; BIBL. 12 REF.Article

PHENOTYPE D'ACETYLATION DE L'ISOMIAZIDE. REVUE DE LA LITTERATUREBOURAOUI K.1980; TUNISIE MED.; ISSN 0041-4131; TUN; DA. 1980; VOL. 58; NO 5; PP. 655-660; ABS. ARA/ENG; BIBL. 59 REF.Article

GENETIC VARIATION IN N-ACETYLATION OF CARCINOGENIC ARYLAMINES BY HUMAN AND RABBIT LIVERGLOWINSKI IB; RADTKE HE; WEBER WW et al.1978; MOLEC. PHARMACOL.; USA; DA. 1978; VOL. 14; NO 5; PP. 940-949; BIBL. 51 REF.Article

EFFECT OF DOSE ON ACETYLATOR PHENOTYPE DISTRIBUTION OF HYDRALAZINETIMBRELL JA; HARLAND SJ; FACCHINI V et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 3; PP. 337-343; BIBL. 18 REF.Article

HUMAN ACETYLATOR POLYMORPHISM: ESTIMATE OF ALLELE FREQUENCY IN LYBIA AND DETAILS OF GLOBAL DISTRIBUTIONKARIM AKMB; ELFELLAH MS; EVANS DAP et al.1981; J. MED. GENET.; ISSN 0022-2593; GBR; DA. 1981; VOL. 18; NO 5; PP. 325-330; BIBL. 59 REF.Article